<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref33">
 <label>33</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Anagnostou</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Kranidioti</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Micha</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Is the availability of direct antiviral agents (DAAs) enough to treat chronic hepatitis C (CHC) and achieve HCV elimination among people who use drugs (PWUD)?What do the real world data suggest?</article-title>
  <source>7
   <sup>th</sup> International Symposium on Hepatitis Care in Substance Users. Cascais/Portugal, 19-21 September
  </source>
  <year>2018</year>
 </element-citation>
</ref>
